Full Press Release Details
ALCOHOL USE DISORDER
AND SUBSTANCE USE DISORDER
Agreement ("Agreement") is effective as of this 3rd day of September 2024, ("Effective
Date") between PSYENCE UK GROUP LTD, a private company incorporated in England and Wales under company registration number
13986347 ("PSYUK") and PSYENCE BIOMEDICAL LTD, a publicly listed company incorporated in the Province of Ontario,
Canada with Ontario corporation number 1000582144 ("PBM"). PSYUK and PBM may be referred to herein singularly as a "party"
and collectively as the "parties".
of Use" and collectively the "Fields of Use").
CONSIDERATION of the premises and mutual covenants contained herein and for other good and valuable consideration, THE PARTIES
HERETO AGREE AS FOLLOWS:
In this Agreement, the
following terms shall have the respective meanings set out below and grammatical variations of such terms shall have the corresponding
of the Fields of Use in accordance with Applicable Laws ("Licenses").
the "Development Milestones").
For the purpose of this
paragraph, disclosures made of Confidential Information that are specific in nature shall not be deemed within the foregoing exceptions
merely because they are embraced by more general information available to the public or in the possession of the recipient.
in no case shall any exclusivity persists after the expiry of the Term.
PSYUK gives no warranty,
express or implied, as to the fitness of the Licensed IP for the Trials or Commercialization other than that:
ANY PROVISION OF THIS AGREEMENT TO THE CONTRARY, EXCEPT IN THE EVENT OF GROSS NEGLIGENCE OR WILFUL MISCONDUCT, NEITHER PARTY, NOR ITS
DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, AND AFFILIATES WILL BE LIABLE TO THE OTHER
PARTY FOR INCIDENTAL, EXEMPLARY, CONSEQUENTIAL, INDIRECT, OR PUNITIVE DAMAGES OF ANY KIND, INCLUDING
LOST PROFITS, LOST OR DIMINISHED PRODUCTION, BUSINESS INTERRUPTION OR CLAIMS OF CUSTOMERS OR OTHER THIRD PARTIES, REGARDLESS OF WHETHER
THE INDEMNIFYING PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, AND REGARDLESS OR WHETHER BASED UPON A CLAIM OR ACTION OF
CONTRACT, WARRANTY, NEGLIGENCE, STRICT LIABILITY, OTHER TORT, OR OTHERWISE.
that the amount of the PSYUK's indemnification obligations under Section 13.1(b)(ii) shall be limited to the aggregate
amount of payments made to PSYUK by PBM under this Agreement.
Address: 23 NOEL STREET,
LONDON, ENGLAND W1F 8GT
ATT: Christopher Bull
Address: 121 Richmond
Street West, Penthouse Suite 1300, Toronto, Ontario, M5H 2K1
ATT: Neil Maresky, copying
The parties have caused this Agreement
to be executed as of the Effective Date.
| PSYENCE UK GROUP LTD | PSYENCE BIOMEDICAL LTD | |||
| By: | By: | |||
| (Signature) | (Signature) | |||
| Name: | Christopher Bull | Name: | Neil Maresky | |
| (Print - Block Letters) | (Print - Block Letters) | |||
| Title: | Director | Title: | Director and CEO | |
| (Print - Block Letters) | (Print - Block Letters) | |||
| Date: | September 3, 2024 | Date | September 3, 2024 |